Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?

Recent studies have demonstrated that combined substitutions of rifapentine for rifampin and moxifloxacin for isoniazid in the standard, daily, short-course regimen of rifampin, isoniazid, and pyrazinamide produces stable cure in 12 weeks or less. This study was designed to more precisely evaluate the contribution of moxifloxacin and isoniazid to rifapentine-based regimens.


Published in:
American journal of respiratory and critical care medicine, 178, 9, 989-93
Year:
2008
ISSN:
1535-4970
Laboratories:




 Record created 2012-04-27, last modified 2018-09-13


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)